Es gab 50 kürzliche Insider-Transaktionen für Theseus Pharmaceuticals, Inc. (THRX), darunter 39 Käufe und 8 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $29.44M und die gesamten Insider-Verkäufe auf $4.71M.
Bedeutende Insider mit kürzlicher Aktivität umfassen Orbimed Advisors Llc, Hayden Donald J Jr, Gordon Carl L. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — THRX
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2024-02-14 |
Orbimed Advisors Llc |
10 Percent Owner |
Übernahmeangebot (Verkauf) |
650,600 |
$4.05 |
$2.63M |
- |
| 2024-02-14 |
Hayden Donald J Jr |
Director |
Aktienrückgabe |
3,250 |
- |
- |
- |
| 2024-02-14 |
Gordon Carl L |
10 Percent Owner |
Aktienrückgabe |
3,250 |
- |
- |
- |
| 2024-02-14 |
Stein Steven H |
Director |
Aktienrückgabe |
3,250 |
- |
- |
- |
| 2024-02-14 |
Dukes Iain D. |
Director |
Aktienrückgabe |
61,549 |
$4.03 |
$248.33K |
- |
| 2024-02-14 |
Yi Kathy |
Director |
Aktienrückgabe |
99,634 |
$4.03 |
$401.99K |
- |
| 2024-02-14 |
Dahms Bradford D. |
President and CFO |
Aktienrückgabe |
332,114 |
$4.03 |
$1.34M |
- |
| 2023-11-06 |
Shakespeare William |
See Remarks |
Optionsausübung (Verkauf) |
251,084 |
$0.32 |
$80.35K |
93,260 |
| 2023-07-17 |
Orbimed Advisors Llc |
10 Percent Owner |
Informierter Kauf |
151,450 |
$3.05 |
$461.92K |
650,600 |
| 2023-07-17 |
Gordon Carl L |
10 Percent Owner |
Informierter Kauf |
151,450 |
$3.05 |
$461.92K |
650,600 |
| 2023-07-17 |
Foresite Capital Management V, Llc |
10 Percent Owner |
Informierter Kauf |
176,550 |
$2.97 |
$524.35K |
1,385,825 |
| 2023-06-13 |
Hayden Donald J Jr |
Director |
RSU-Zuteilung |
3,250 |
- |
- |
3,250 |
| 2023-06-13 |
Gordon Carl L |
10 Percent Owner |
RSU-Zuteilung |
3,250 |
- |
- |
3,250 |
| 2023-06-13 |
Stein Steven H |
Director |
RSU-Zuteilung |
3,250 |
- |
- |
3,250 |
| 2023-06-13 |
Dukes Iain D. |
Director |
RSU-Zuteilung |
3,250 |
- |
- |
3,250 |
| 2023-06-13 |
Yi Kathy |
Director |
RSU-Zuteilung |
3,250 |
- |
- |
3,250 |
| 2023-03-01 |
Clackson Timothy P |
President and CEO |
RSU-Zuteilung |
45,625 |
- |
- |
45,625 |
| 2023-03-01 |
Dahms Bradford D. |
Chief Financial Officer |
RSU-Zuteilung |
17,500 |
- |
- |
17,500 |
| 2023-03-01 |
Kerstein David |
Chief Medical Officer |
RSU-Zuteilung |
17,500 |
- |
- |
17,500 |
| 2023-03-01 |
Rivera Victor |
Chief Scientific Officer |
RSU-Zuteilung |
16,250 |
- |
- |
16,250 |
| 2023-03-01 |
Shakespeare William |
See Remarks |
RSU-Zuteilung |
21,250 |
- |
- |
21,250 |
| 2023-02-17 |
Clackson Timothy P |
President and CEO |
RSU-Zuteilung |
273,750 |
$11.42 |
$3.13M |
273,750 |
| 2023-02-17 |
Dahms Bradford D. |
Chief Financial Officer |
RSU-Zuteilung |
105,000 |
$11.42 |
$1.2M |
105,000 |
| 2023-02-17 |
Kerstein David |
Chief Medical Officer |
RSU-Zuteilung |
105,000 |
$11.42 |
$1.2M |
105,000 |
| 2023-02-17 |
Rivera Victor |
Chief Scientific Officer |
RSU-Zuteilung |
97,500 |
$11.42 |
$1.11M |
97,500 |
| 2023-02-17 |
Shakespeare William |
See Remarks |
RSU-Zuteilung |
127,500 |
$11.42 |
$1.46M |
127,500 |
| 2022-12-30 |
Hayden Donald J Jr |
Director |
Informierter Kauf |
9,900 |
$5.00 |
$49.49K |
10,000 |
| 2022-12-29 |
Hayden Donald J Jr |
Director |
Informierter Kauf |
100 |
$5.00 |
$500.00 |
100 |
| 2022-12-29 |
Foresite Capital Management V, Llc |
Director |
Informierter Kauf |
250,000 |
$5.00 |
$1.25M |
1,209,275 |
| 2022-11-30 |
Dahms Bradford D. |
Chief Financial Officer |
Informierter Kauf |
1,502 |
$6.66 |
$10K |
6,142 |
| 2022-11-11 |
Clackson Timothy P |
President and CEO |
Informierter Kauf |
2,500 |
$6.80 |
$17K |
351,030 |
| 2022-11-07 |
Orbimed Advisors Llc |
Director |
Informierter Kauf |
192,000 |
$5.21 |
$1M |
16,734,518 |
| 2022-11-07 |
Gordon Carl L |
Director |
Informierter Kauf |
192,000 |
$5.21 |
$1M |
16,734,518 |
| 2022-10-17 |
Stein Steven H |
Director |
Unbekannt |
- |
- |
- |
- |
| 2022-10-17 |
Stein Steven H |
Director |
RSU-Zuteilung |
60,000 |
- |
- |
60,000 |
| 2022-06-10 |
Gordon Carl L |
10 Percent Owner |
RSU-Zuteilung |
30,000 |
$5.75 |
$172.5K |
30,000 |
| 2022-06-10 |
Dukes Iain D. |
Chairman |
RSU-Zuteilung |
15,000 |
- |
- |
15,000 |
| 2022-06-10 |
Yi Kathy |
Director |
RSU-Zuteilung |
30,000 |
- |
- |
30,000 |
| 2022-06-09 |
Foresite Capital Management V, Llc |
Director |
Unbekannt |
- |
- |
- |
959,275 |
| 2022-05-17 |
Hayden Donald J Jr |
Director |
Unbekannt |
- |
- |
- |
- |
| 2022-05-17 |
Hayden Donald J Jr |
Director |
RSU-Zuteilung |
60,000 |
$8.02 |
$481.2K |
60,000 |
| 2022-02-18 |
Clackson Timothy P |
President and CEO |
RSU-Zuteilung |
450,000 |
$11.21 |
$5.04M |
450,000 |
| 2022-02-18 |
Dahms Bradford D. |
Chief Financial Officer |
RSU-Zuteilung |
150,000 |
$11.21 |
$1.68M |
150,000 |
| 2022-02-18 |
Kerstein David |
Chief Medical Officer |
RSU-Zuteilung |
150,000 |
$11.21 |
$1.68M |
150,000 |
| 2022-02-18 |
Dalgarno David |
Chief Technical Officer |
RSU-Zuteilung |
130,000 |
$11.21 |
$1.46M |
130,000 |
| 2022-02-18 |
Rivera Victor |
Chief Scientific Officer |
RSU-Zuteilung |
130,000 |
$11.21 |
$1.46M |
130,000 |
| 2022-02-18 |
Shakespeare William |
See Remarks |
RSU-Zuteilung |
180,000 |
$11.21 |
$2.02M |
180,000 |
| 2022-01-21 |
Orbimed Advisors Llc |
10 Percent Owner |
Informierter Kauf |
111,896 |
$9.97 |
$1.12M |
16,542,652 |
| 2022-01-21 |
Gordon Carl L |
10 Percent Owner |
Informierter Kauf |
111,896 |
$9.97 |
$1.12M |
16,542,652 |
| 2022-01-20 |
Orbimed Advisors Llc |
10 Percent Owner |
Informierter Kauf |
35,000 |
$9.95 |
$348.25K |
16,430,756 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
